TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Central Oncology Group Phase Out Approved; Board Impressed By Unanimous CCIRC Vote April 2, 1976
TCL Archive In Brief: Zubrod “One Person Who Made The Difference” In Drug Program, DeVita Says in Center’s 25th July 27, 1984
